This illustrates that PTEN controls G6PD expression through two steps by inhibiting G6PD pre-mRNA splicing, which suggests that G6PD is a key regulatory factor of PTEN in controlling tumor progression and implies that G6PD is a valuable target for anticancer treatments. The gene discussed is PTEN; the disease is neoplasm.